Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
B. K. Sharma, Kirti Sarbhai, P. Singh & Susheela Sharma. (2008) Quantitative structure-activity relationship study on affinity profile of a series of 1,8-naphthyridine antagonists toward bovine adenosine receptors. Journal of Enzyme Inhibition and Medicinal Chemistry 23:3, pages 437-443.
Read now
Read now
Articles from other publishers (30)
Bruno Gonçalves Pinheiro, Diandra Araújo Luz, Sabrina de Carvalho Cartágenes, Luanna de Melo Pereira Fernandes, Sarah Viana Farias, Natália Harumi Correa Kobayashi, Enéas Andrade Fontes-Júnior, Samira G. Ferreira, Rodrigo A. Cunha, Rui Daniel Prediger & Cristiane do Socorro Ferraz Maia. (2022) The Role of the Adenosine System on Emotional and Cognitive Disturbances Induced by Ethanol Binge Drinking in the Immature Brain and the Beneficial Effects of Caffeine. Pharmaceuticals 15:11, pages 1323.
Crossref
Crossref
Siamak Reyhani-Rad & Javad Mahmoudi. (2016) Effect of adenosine A2A receptor antagonists on motor disorders induced by 6-hydroxydopamine in rat. Acta Cirurgica Brasileira 31:2, pages 133-137.
Crossref
Crossref
Gitte Kobber?e Mikkelsen, Morten Langg?rd, Tenna Juul Schr?der, Mads Kreilgaard, Erling B. J?rgensen, Guillaume Brandt, Yann Griffon, Ray Boffey & Benny Bang-Andersen. (2015) Synthesis and SAR studies of analogues of 4-(3,3-dimethyl-butyrylamino)-3,5-difluoro-N-thiazol-2-yl-benzamide (Lu AA41063) as adenosine A2A receptor ligands with improved aqueous solubility. Bioorganic & Medicinal Chemistry Letters 25:6, pages 1212-1216.
Crossref
Crossref
Manuel de Lera Ruiz, Yeon-Hee Lim & Junying Zheng. (2013)
Adenosine A
2A
Receptor as a Drug Discovery Target
. Journal of Medicinal Chemistry 57:9, pages 3623-3650.
Crossref
Crossref
Geoffrey Burnstock & Alexei VerkhratskyGeoffrey Burnstock & Alexei Verkhratsky. 2012. Purinergic Signalling and the Nervous System. Purinergic Signalling and the Nervous System
433
581
.
Anna Drabczyńska, Olga Yuzlenko, Meryem Köse, Minka Paskaleva, Anke C. Schiedel, Janina Karolak-Wojciechowska, Jadwiga Handzlik, Tadeusz Karcz, Kamil Kuder, Christa E. Müller & Katarzyna Kieć-Kononowicz. (2011) Synthesis and biological activity of tricyclic cycloalkylimidazo-, pyrimido- and diazepinopurinediones. European Journal of Medicinal Chemistry 46:9, pages 3590-3607.
Crossref
Crossref
Rashad Al-Salahi, Detlef Geffken & Maria Koellner. (2011) A New Series of 2-Alkoxy(aralkoxy)-[1,2,4]triazolo[1,5-a]quinazolin-5-ones as Adenosine Receptor Antagonists. CHEMICAL & PHARMACEUTICAL BULLETIN 59:6, pages 730-733.
Crossref
Crossref
. (2009) Brain Poster Session: Neurologic Disease. Journal of Cerebral Blood Flow & Metabolism 29:1_suppl, pages S273-S287.
Crossref
Crossref
Gloria Cristalli, Christa E. Müller & Rosaria Volpini. 2009. Adenosine Receptors in Health and Disease. Adenosine Receptors in Health and Disease
59
98
.
Anna Drabczyńska, Christa E. Müller, Janina Karolak-Wojciechowska, Britta Schumacher, Anke Schiedel, Olga Yuzlenko & Katarzyna Kieć-Kononowicz. (2007) N9-Benzyl-substituted 1,3-dimethyl- and 1,3-dipropyl-pyrimido[2,1-f]purinediones: Synthesis and structure–activity relationships at adenosine A1 and A2A receptors. Bioorganic & Medicinal Chemistry 15:14, pages 5003-5017.
Crossref
Crossref
Luisa Minghetti, Anita Greco, Rosa Luisa Potenza, Antonella Pezzola, David Blum, Kadiombo Bantubungi & Patrizia Popoli. (2007) Effects of the Adenosine A2A Receptor Antagonist SCH 58621 on Cyclooxygenase-2 Expression, Glial Activation, and Brain-Derived Neurotrophic Factor Availability in a Rat Model of Striatal Neurodegeneration. Journal of Neuropathology and Experimental Neurology 66:5, pages 363-371.
Crossref
Crossref
Geoffrey Burnstock. (2007) Physiology and Pathophysiology of Purinergic Neurotransmission. Physiological Reviews 87:2, pages 659-797.
Crossref
Crossref
Gloria Cristalli, Barbara Cacciari, Diego Dal Ben, Catia Lambertucci, Stefano Moro, Giampiero Spalluto & Rosaria Volpini. (2007) Highlights on the Development of A2A Adenosine Receptor Agonists and Antagonists. ChemMedChem 2:3, pages 260-281.
Crossref
Crossref
Kui Xu, Elena Bastia & Michael Schwarzschild. (2005) Therapeutic potential of adenosine A2A receptor antagonists in Parkinson's disease. Pharmacology & Therapeutics 105:3, pages 267-310.
Crossref
Crossref
Gang Yao, Serajul Haque, Li Sha, Gnanasambandam Kumaravel, Joy Wang, Thomas M. Engber, Eric T. Whalley, Patrick R. Conlon, Hexi Chang, William F. Kiesman & Russell C. Petter. (2005) Synthesis of alkyne derivatives of a novel triazolopyrazine as A2A adenosine receptor antagonists. Bioorganic & Medicinal Chemistry Letters 15:3, pages 511-515.
Crossref
Crossref
Daniela Catarzi, Vittoria Colotta, Flavia Varano, Francesca Romana Calabri, Ombretta Lenzi, Guido Filacchioni, Letizia Trincavelli, Claudia Martini, Andrea Tralli, Christian Montopoli & Stefano Moro. (2005) 2-Aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists. Bioorganic & Medicinal Chemistry 13:3, pages 705-715.
Crossref
Crossref
Anna Drabczyńska, Christa E. Müller, Britta Schumacher, Sonja Hinz, Janina Karolak-Wojciechowska, Barbara Michalak, Elżbieta Pękala & Katarzyna Kieć-Kononowicz. (2004) Tricyclic oxazolo[2,3-f]purinediones: potency as adenosine receptor ligands and anticonvulsants. Bioorganic & Medicinal Chemistry 12:18, pages 4895-4908.
Crossref
Crossref
Maria Teresa Tebano, Annita Pintor, Claudio Frank, Maria Rosaria Domenici, Alberto Martire, Rita Pepponi, Rosa Luisa Potenza, Rosa Grieco & Patrizia Popoli. (2004) Adenosine A2A receptor blockade differentially influences excitotoxic mechanisms at pre- and postsynaptic sites in the rat striatum. Journal of Neuroscience Research 77:1, pages 100-107.
Crossref
Crossref
Daniela Catarzi, Vittoria Colotta, Flavia Varano, Guido Filacchioni, Claudia Martini, Letizia Trincavelli & Antonio Lucacchini. (2004) 1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists. Il Farmaco 59:2, pages 71-81.
Crossref
Crossref
Ennio Ongini. (2003)
Introduction: Adenosine A
2A
receptors in nonlocomotor features of Parkinson’s disease
. Neurology 61:11_suppl_6.
Crossref
Crossref
Maria L. Trincavelli, Alessandra Falleni, Beatrice Chelli, Daniela Tuscano, Barbara Costa, Vittorio Gremigni, Antonio Lucacchini & Claudia Martini. (2003) A2A adenosine receptor ligands and proinflammatory cytokines induce PC 12 cell death through apoptosis. Biochemical Pharmacology 66:10, pages 1953-1962.
Crossref
Crossref
Mark J. Millan. (2003) The neurobiology and control of anxious states. Progress in Neurobiology 70:2, pages 83-244.
Crossref
Crossref
J.A. Ribeiro, A.M. Sebastião & A. de Mendonça. (2002) Adenosine receptors in the nervous system: pathophysiological implications. Progress in Neurobiology 68:6, pages 377-392.
Crossref
Crossref
Elena Bastia, Katia Varani, Angela Monopoli & Rosalia Bertorelli. (2002) Effects of A1 and A2A adenosine receptor ligands in mouse acute models of pain. Neuroscience Letters 328:3, pages 241-244.
Crossref
Crossref
Maria Teresa Tebano, Maria Rosaria Domenici & Patrizia Popoli. (2002) SCH 58261 differentially influences quinolinic acid-induced effects in striatal and in hippocampal slices. European Journal of Pharmacology 450:3, pages 253-257.
Crossref
Crossref
Serena Latini & Felicita Pedata. (2008) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. Journal of Neurochemistry 79:3, pages 463-484.
Crossref
Crossref
Malika El Yacoubi, Catherine Ledent, Marc Parmentier, Rosalia Bertorelli, Ennio Ongini, Jean Costentin & Jean‐Marie Vaugeois. (2009)
Adenosine A
2A
receptor antagonists are potential antidepressants: evidence based on pharmacology and A
2A
receptor knockout mice
. British Journal of Pharmacology 134:1, pages 68-77.
Crossref
Crossref
Annita Pintor, Davide Quarta, Antonella P?zzola, Rosaria Reggio & Patrizia Popoli. (2001) SCH 58261 (an adenosine A2A receptor antagonist) reduces, only at low doses, K+-evoked glutamate release in the striatum. European Journal of Pharmacology 421:3, pages 177-180.
Crossref
Crossref
Ennio Ongini, Angela Monopoli, Barbara Cacciari & Pier Giovanni Baraldi. (2001) Selective adenosine A2A receptor antagonists. Il Farmaco 56:1-2, pages 87-90.
Crossref
Crossref
Ennio Ongini, Angela Monopoli, Francesco Impagnatiello, Silva Fredduzzi, Michael Schwarzschild & Jiang-Fan Chen. (2001) Dual actions of A2A adenosine receptor antagonists on motor dysfunction and neurodegenerative processes. Drug Development Research 52:1-2, pages 379-386.
Crossref
Crossref